NOD2 and Blau syndrome: Although pathological studies reveal that granulomas in Blau syndrome patients are accompanied by a prominent expression of IFN-γ (47), the details regarding the molecular mechanism(s) by which NOD2 mutations drive the pathogenesis of Blau syndrome are unclear.